| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |